<DOC>
	<DOCNO>NCT02115022</DOCNO>
	<brief_summary>Accurate staging patient pancreatic cancer critical avoid expense , morbidity , mortality relate unnecessary surgery . While several test available assess patient , consensus achieve optimal approach . As matter fact , pancreatic cancer stag discuss controversially due conflict evidence certainly EUS lose ground due improvement CT technology . Thus , role EUS EUS-guided FNA vary among treatment center . The present study design well define role EUS predict resectability , compare high resolution cross-sectional imaging .</brief_summary>
	<brief_title>EUS vs. MDCT Pancreatic Malignancy</brief_title>
	<detailed_description>Registry procedure : - HIGH-RESOLUTION PANCREATIC PROTOCOL COMPUTED TOMOGRAPHY ( CT ) SCAN EXAMINATION : perform least 16-section multi-detector row ( MD ) CT review use multi-planar reconstruction , image obtain follow oral administration water pancreatic protocol intravenous iopamidol , image acquire pancreatic portal venous phase contrast enhancement , reconstruct thin slice ( 1 mm - pancreatic phase 2 mm - portal venous phase increment ) . - EUS EXAMINATION : perform within 2 week MDCT , aim visualization pancreas , main surround vascular structure , celiac mediastinal lymph node , liver leave adrenal gland , EUS-FNA perform discretion investigator/examiner confirm/exclude metastasis confirmation malignancy primary tumor . Patients confirm EUS distant metastasis defer planned surgical intervention . - SURGICAL INTERVENTION : aiming provide curative intent ( R0 ) resection . - HISTOPATHOLOGICAL POSTOPERATIVE STAGING : evaluation loco-regional invasiveness degree complete surgical resection ( R0/R1 ) . - FOLLOW-UP OF PATIENTS : phone-calls every 6 month basis , 2 year , retain follow data : survival ( ) , date decease direct cause ( applicable ) , presence tumor recurrence ( ) .</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<criteria>adult ( â‰¥ 18 year age ) patient ; presence confirm pancreatic mass ( suspect neoplastic ) deem resectable borderline resectable multislice ( least 16 simultaneously acquire slice ) pancreatic protocol compute tomography ( CT ) ; patient fit willing undergo surgery curative ( R0 ) intent ; sign inform consent . presence significant comorbidities contraindicate pancreatic resection ; previous neoadjuvant oncologic therapy ; distant metastasis ; lack discernment ; refusal sign inform consent..</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>pancreatic cancer</keyword>
	<keyword>resectability</keyword>
	<keyword>endosonography ( EUS )</keyword>
	<keyword>multidetection computer tomography ( MDCT )</keyword>
	<keyword>stag</keyword>
</DOC>